GlassScriptPhysician profile
Jared C Yarnell
NPI 1609215797
$27,135.33
in general payments reported to CMS, 2019-2025
76 companies · $4,631 in 2025
The $4,631 reported for 2025 was more than what 84% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,515 · 2020: $1,909 · 2021: $3,228 · 2022: $3,623 · 2023: $4,716 · 2024: $5,513 · 2025: $4,631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $13.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,847.10 |
| Education | $13.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,148.59 | 2020-2025 | Ubrelvy, Botox, Qulipta |
| Ucb, INC. | $2,206.64 | 2019-2025 | Briviact, Fintepla, Nayzilam |
| Pfizer INC. | $1,740.38 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $1,303.96 | 2019-2025 | Ultomiris, Soliris |
| Novartis Pharmaceuticals Corporation | $1,128.84 | 2019-2025 | |
| Lilly USA, LLC | $890.90 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Teva Pharmaceuticals USA, INC. | $882.12 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbott Laboratories | $862.63 | 2021-2025 | Infinity |
| Mallinckrodt Hospital Products INC. | $843.86 | 2020-2025 | Acthar |
| Medtronic USA, INC. | $735.28 | 2019 | |
| Allergan, INC. | $711.78 | 2019-2022 | |
| Emd Serono, INC. | $707.80 | 2019-2024 | Mavenclad |
| Eisai INC. | $610.44 | 2019-2025 | |
| Sk Life Science, INC. | $598.91 | 2020-2025 | |
| Biogen, INC. | $544.33 | 2020-2025 | Tysabri, Vumerity, Skyclarys |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $544.08 | 2021-2025 | Xeomin, Inbrija |
| Neurocrine Biosciences, INC. | $514.74 | 2021-2025 | Ingrezza, Ongentys |
| Amgen INC. | $510.46 | 2019-2025 | Uplizna |
| Amneal Pharmaceuticals LLC | $460.87 | 2019-2024 | Rytary |
| Mdd US Operations, LLC | $457.22 | 2019-2022 | |
| Argenx US, INC. | $423.23 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Harmony Biosciences LLC | $411.99 | 2020-2025 | Wakix |
| Genzyme Corporation | $399.64 | 2019-2025 | |
| Genentech USA, INC. | $394.07 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Lundbeck LLC | $393.91 | 2019-2025 | Vyepti |
| Neurelis, INC. | $390.81 | 2022-2025 | Valtoco |
| Acadia Pharmaceuticals INC | $375.52 | 2019-2025 | Nuplazid, Daybue |
| Tg Therapeutics, INC. | $366.73 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $353.98 | 2020-2025 | |
| Biohaven Pharmaceuticals, INC. | $307.45 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $300.49 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $299.79 | 2019-2025 | Firdapse |
| Supernus Pharmaceuticals, INC. | $246.70 | 2019-2022 | |
| Celgene Corporation | $218.74 | 2021-2025 | Zeposia |
| Ani Pharmaceuticals, INC. | $176.21 | 2022-2025 | Purified Cortrophin Gel |
| Otsuka America Pharmaceutical, INC. | $173.07 | 2023-2025 | Rexulti |
| Tanabe Pharma America, INC. | $153.45 | 2021-2024 | |
| Axsome Therapeutics, INC. | $148.11 | 2022-2025 | Sunosi, Symbravo |
| Kyowa Kirin, INC. | $141.69 | 2020-2024 | Nourianz |
| Biohaven Pharmaceutical Holding Company LTD. | $141.28 | 2022 | |
| Alnylam Pharmaceuticals INC. | $136.16 | 2022-2023 | Onpattro |
| Merz North America, INC. | $135.34 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $133.88 | 2024-2025 | Ponvory |
| Sunovion Pharmaceuticals INC. | $132.98 | 2021-2022 | |
| Boston Scientific Corporation | $115.16 | 2023-2025 | Vercise, Wavewriter Alpha Prime 16 |
| Livanova USA, INC. | $96.46 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Takeda Pharmaceuticals U.S.A., INC. | $92.97 | 2024 | Hyqvia |
| Springworks Therapeutics, INC. | $88.67 | 2025 | Gomekli |
| Janssen Biotech, INC. | $83.44 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $79.81 | 2024-2025 | Wainua |
| Grifols USA, LLC | $77.34 | 2021-2025 | Gamunex-C |
| Impel Pharmaceuticals INC. | $67.01 | 2022-2023 | Trudhesa |
| Bausch Health US, LLC | $59.36 | 2019-2020 | |
| Amylyx Pharmaceuticals, INC. | $45.40 | 2023 | Relyvrio |
| E.R. Squibb & Sons, L.L.C. | $42.76 | 2020-2021 | |
| Insightec,INC | $41.58 | 2025 | Exablate |
| Avion Pharmaceuticals | $36.87 | 2023 | Dhivy |
| Janssen Pharmaceuticals, INC | $36.59 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $36.07 | 2019-2021 | |
| Banner Life Sciences, LLC | $35.26 | 2021 | |
| Almatica Pharma LLC | $31.34 | 2021 | |
| Nevro Corp. | $27.47 | 2023 | Senza |
| Nobelpharma America, LLC | $26.60 | 2024 | |
| Ns Pharma, INC. | $24.76 | 2023 | Viltepso |
| C2n Diagnostics, LLC | $24.27 | 2025 | Precivityad2 |
| Octapharma USA, INC. | $23.90 | 2023 | Panzyga |
| Vertical Pharmaceuticals, LLC | $21.59 | 2019 | |
| Csl Behring | $21.27 | 2020 | |
| Sumitomo Pharma America, INC. | $20.63 | 2024 | Aptiom |
| Assertio Therapeutics, INC. | $19.83 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $19.58 | 2022 | |
| Acorda Therapeutics, INC | $17.66 | 2019 | |
| Greenwich Biosciences, INC. | $17.25 | 2021 | |
| Collegium Pharmaceutical, INC. | $16.49 | 2022 | |
| Upsher-Smith Laboratories LLC | $15.55 | 2019 | |
| Medtronic, INC. | $13.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Yarnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.